Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Aspirin may lower cancer risk in older women

NCT ID NCT07281547

First seen Dec 16, 2025 · Last updated May 22, 2026 · Updated 23 times

Summary

This study tests whether taking low-dose aspirin can reduce inflammation and prevent endometrial cancer in postmenopausal women who have certain changes in their uterine lining. About 25 women will be randomly assigned to take aspirin or not, and researchers will measure inflammation markers in tissue samples. The goal is to see if aspirin, a common anti-inflammatory drug, can lower cancer risk.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Mayo Clinic in Florida

    Jacksonville, Florida, 32224-9980, United States

    Contact Phone: •••-•••-••••

    Contact

    Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.